α-tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain

Journal of Neuroimmunology

Volumn 149, Issue 1-2, 2004, Pages 101-109

  Godbout, Jonathan P ^a   Berg, Brian M ^a   Kelley, Keith W ^a   Johnson, Rodney W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Tocopherol; Brain; Cytokines; Lipopolysaccharide; Mice; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PEROXIDE; PEROXY RADICAL; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; INTRACELLULAR SPACE; LIPID PEROXIDATION; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; BRAIN; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXTRACELLULAR SPACE; FLOW CYTOMETRY; INTERLEUKIN-6; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED BALB C; MICROGLIA; REACTIVE OXYGEN SPECIES;

EID: 1542710617     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.12.017     Document Type: Article

References (46)

1. Adolfsson O., Huber B.T., Meydani S.N. Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity. J. Immunol. 167:2001;3809-3817.
2. Bellezzo J.M., Leingang K.A., Bulla G.A., Britton R.S., Bacon B.R., Fox E.S. Modulation of lipopolysaccharide-mediated activation in rat Kupffer cells by antioxidants. J. Lab. Clin. Med. 131:1998;36-44.
3. Berg B., Godbout J.P., Kelley K.W., Johnson R.W. α-Tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav. Immun. 18:2004;149-157.
4. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272:1997;20313-20316.
5. Bray T.M. Dietary antioxidants and assessment of oxidative stress. Nutrition. 16:2000;578-581.
6. Brigelius-Flohe R., Traber M.G. Vitamin E: function and metabolism. FASEB J. 13:1999;1145-1155.
7. Cadenas S., Cadenas A.M. Fighting the stranger-antioxidant protection against endotoxin toxicity. Toxicology. 180:2002;45-63.
8. Christen Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71:2000;621S-629S.
9. Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G.Z., Ryu S.Y. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol. 150:1993;5219-5230.
10. Devaraj S., Jialal I. Alpha Tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic. Biol. Med. 29:2000;790-792.
11. Dikalov S.I., Dikalova A.E., Mason R.P. Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. Arch. Biochem. Biophys. 402:2002;218-226.
12. Fahn S. An open trial of high-dosage antioxidants in early Parkinson's disease. Am. J. Clin. Nutr. 53:1991;380S-382S.
13. Forster M.J., Dubey A., Dawson K.M., Stutts W.A., Lal H., Sohal R.S. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. U. S. A. 93:1996;4765-4769.
14. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell. Signal. 13:2001;85-94.
15. Haddad J.J. Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem. Biophys. Res. Commun. 296:2002;847-856.
16. Heyen J.R., Ye S., Finck B.N., Johnson R.W. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77:2000;138-147.
17. Jialal I., Traber M., Devaraj S. Is there a vitamin E paradox? Curr. Opin. Lipidol. 12:2001;49-53.
18. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., Broussard S.R. Cytokine-induced sickness behavior. Brain Behav. Immun. 17:2003;112-118.
19. Kheir-Eldin A.A., Motawi T.K., Gad M.Z., Abd-ElGawad H.M. Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int. J. Biochem. Cell Biol. 33:2001;475-482.
20. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
21. Laflamme N., Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15:2001;155-163.
22. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25:2000;294-297.
23. Li N., Karin M. Is NF-kappaB the sensor of oxidative stress? FASEB J. 13:1999;1137-1143.
24. Macdonald J., Galley H.F., Webster N.R. Oxidative stress and gene expression in sepsis. Br. J. Anaesth. 90:2003;221-232.
25. Martin A., Janigian D., Shukitt-Hale B., Prior R.L., Joseph J.A. Effect of vitamin E intake levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain Res. 845:1999;50-59.
26. Mercurio F., Manning A.M. NF-kappaB as a primary regulator of the stress response. Oncogene. 18:1999;6163-6171.
27. Meydani M. Antioxidants and cognitive function. Nutr. Rev. 59:2001;S75-S80. (Discussion S80-S72).
28. Meydani M., Lipman R.D., Han S.N., Wu D., Beharka A., Martin K.R., Bronson R., Cao G., Smith D., Meydani S.N. The effect of long-term dietary supplementation with antioxidants. Ann. N. Y. Acad. Sci. 854:1998;352-360.
29. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., Perno C.F. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 24:2001;411-416.
30. Mrak R.E., Griffin S.T., Graham D.I. Aging-associated changes in human brain. J. Neuropathol. Exp. Neurol. 56:1997;1269-1275.
31. Murray C.A., Lynch M.A. Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. J. Biol. Chem. 273:1998;12161-12168.
32. Packer L. alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury. Drug Metab. Rev. 30:1998;245-275.
33. Pathania V., Syal N., Pathak C.M., Khanduja K.L. Vitamin E suppresses the induction of reactive oxygen species release by lipopolysaccharide, interleukin-1beta and tumor necrosis factor-alpha in rat alveolar macrophages. J. Nutr. Sci. Vitaminol. (Tokyo). 45:1999;675-686.
34. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4:2003;103-112.
35. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 17:2003;13-19.
36. Rockwood K., Cosway S., Carver D., Jarrett P., Stadnyk K., Fisk J. The risk of dementia and death after delerium. Age Ageing. 28:1999;551-556.
37. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336:1997;1216-1222.
38. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet. 8441:1985;1313-1315.
39. Straub R.H., Konecna L., Hrach S., Rothe G., Kreutz M., Scholmerich J., Falk W., Lang B. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 83:1998;2012-2017.
40. Toutain P.L., Hidiroglou M., Charmley E. Pharmacokinetics and tissue uptake of D-alpha-tocopherol in sheep following a single intraperitoneal injection. J. Dairy Sci. 78:1995;1561-1566.
41. Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 59:2002;371-378.
42. Webel D.M., Mahan D.C., Johnson R.W., Baker D.H. Pretreatment of young pigs with vitamin E attenuates the elevation in plasma interleukin-6 and cortisol caused by a challenge dose of lipopolysaccharide. J. Nutr. 128:1998;1657-1660.
43. Ye S.M., Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93:1999;139-148.
44. Ye S., Johnson R.W. Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappaB. J. Neuroimmunol. 117:2001;87-96.
45. Ye S.M., Johnson R.W. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation. 9:2001;183-192.
46. Zhang J., Johnston G., Stebler B., Keller E.T. Hydrogen peroxide activates NFkappaB and the interleukin-6 promoter through NFkappaB-inducing kinase. Antioxid. Redox Signal. 3:2001;493-504.